Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories


	Public Health: 45 submissions (showing 1 to 15)

| Page 1 | Page 2 | Page 3 |

Dr. Patrick Ohlmann and Dr. C. Michael Gibson discuss the results of the MISTRAL trial
Dr. C. Michael Gibson, MD, Dr. Patrick Ohlmann

Dr. Cannon and Dr. Gibson discuss the COGENT Trial and the limitations of observational data
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD

Dr. Gibson and Dr. Brindis Compare the Benefits of Randomized Trials and Registries at TCT 2009
Dr. C. Michael Gibson, MD, Dr. Ralph Brindis

Access to Care and Clinical Trials: Are there gender differences and do we have solutions?
Dr. Bonnie Weiner

FDA Perspective: Women in CV Clinical Trials
Ms. Ashley Boam

Dr. Cohen and Dr. Gibson discuss the one year results from the SYNTAX trial
Dr. David J. Cohen, Dr. C. Michael Gibson

Dr. Larry Dean and Dr. C. Michael Gibson discuss the Washington Health Technology Assessment program
Dr. C. Michael Gibson, Dr. Larry Dean

Dr. Lori Mosca and Dr. C. Michael Gibson discuss results from the FIT Heart Trial
Dr. Lori Mosca, MD, Dr. C. Michael Gibson

Data Monitoring Committees: Stopping Boundaries
Dr. Christian Ruff

Time Is Myocardium and Time Is Outcomes
Dr. C. Michael Gibson

Dr. Christian Hamm presents the results of the ON-TIME-2 Study
Dr. Christian Hamm

Dr. Gregory Dehmer and Dr. Vijay Kunadian Discuss What an Interventional Fellow Needs to Know About Statistics
Dr. Vijayalakshmi Kunadian, Dr. Gregory Dehmer

Dr. Magnus Ohman discusses evidence-based medicine therapies for ACS
Dr. Magnus Ohman

Pay For Performance: What Does it Mean, What will be its Impact in CV Care by James Hoekstra, MD
Dr. James Hoekstra

Targeting Hemoglobin and the Use of Erythropoietin and Transfusion in Cardiac Patients
Dr. Peter McCullough